UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, — Los Angeles, California

UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, is a clinical research site located in Los Angeles, California, United States 90095-7059.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma.

Sponsors: Kyowa Kirin Co., Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Los Angeles

Browse all research sites in California · View every site in Los Angeles

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333,?

UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, conducted?

UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, has 1 clinical trials on record. Their work covers Multiple Myeloma.

Is UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, accredited by Crixeo Clinical Trials?

UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333,?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.